Personal information

Other IDs

Scopus Author ID: 6602743981

Activities

Collapse all

Works (38)

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Lung Cancer
2019 | Journal article
DOI: 10.1016/j.lungcan.2019.05.009
EID:

2-s2.0-85065520913
Contributors: Morabito, A.; Piccirillo, M.C.; Maione, P.; Luciani, A.; Cavanna, L.; Bonanno, L.; Filipazzi, V.; Leo, S.; Cinieri, S.; Morgillo, F. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Pembrolizumab in lung cancer: Current evidence and future perspectives

Future Oncology
2019 | Journal article
DOI: 10.2217/fon-2019-0073
EID:

2-s2.0-85073763578
Contributors: Palumbo, G.; Carillio, G.; Manzo, A.; Montanino, A.; Sforza, V.; Costanzo, R.; Sandomenico, C.; Manna, C.L.; Luca, G.D.; Piccirillo, M.C. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial

Lung Cancer
2017 | Journal article
DOI: 10.1016/j.lungcan.2017.02.016
EID:

2-s2.0-85014225187
Contributors: Morabito, A.; Daniele, G.; Costanzo, R.; Favaretto, A.G.; Filipazzi, V.; Rossi, A.; Gebbia, V.; Castiglione, F.; Cavanna, L.; Maiello, E. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Angiogenesis inhibitors in NSCLC

International Journal of Molecular Sciences
2017 | Journal article
DOI: 10.3390/ijms18102021
EID:

2-s2.0-85030095431
Contributors: Manzo, A.; Montanino, A.; Carillio, G.; Costanzo, R.; Sandomenico, C.; Normanno, N.; Piccirillo, M.C.; Daniele, G.; Perrone, F.; Rocco, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies

Annals of oncology : official journal of the European Society for Medical Oncology
2017 | Journal article
DOI: 10.1093/annonc/mdx421.003
EID:

2-s2.0-85050663653
Contributors: Morabito, A.; Cavanna, L.; Luciani, A.; Maione, P.; Bonanno, L.; Piazza, E.; Leo, S.; Cinieri, S.; Morgillo, F.; Burgio, M.A. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors

Critical Reviews in Oncology/Hematology
2016 | Journal article
DOI: 10.1016/j.critrevonc.2015.08.016
EID:

2-s2.0-84952636827
Contributors: Giordano, P.; Manzo, A.; Montanino, A.; Costanzo, R.; Sandomenico, C.; Piccirillo, M.C.; Daniele, G.; Normanno, N.; Carillio, G.; Rocco, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Focus on nintedanib in NSCLC and other tumors

Frontiers in Medicine
2016 | Journal article
DOI: 10.3389/fmed.2016.00068
EID:

2-s2.0-85042514655
Contributors: Manzo, A.; Carillio, G.; Montanino, A.; Costanzo, R.; Sandomenico, C.; Rocco, G.; Morabito, A.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Combining anti-epidermal growth factor receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: We should have known better...

Current Pharmaceutical Design
2014 | Journal article
DOI: 10.2174/13816128113196660762
EID:

2-s2.0-84903985897
Contributors: Di Maio, M.; Morabito, A.; Piccirillo, M.C.; Daniele, G.; Giordano, P.; Costanzo, R.; Sandomenico, C.; Montanino, A.; Rocco, G.; Perrone, F.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Rationale and design of MILES-3 and MILES-4 studies: Two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non-small-cell lung cancer

Clinical Lung Cancer
2014 | Journal article
DOI: 10.1016/j.cllc.2013.11.011
EID:

2-s2.0-84894087464
Contributors: Gridelli, C.; Rossi, A.; Di Maio, M.; Leo, S.; Filipazzi, V.; Favaretto, A.G.; Burgio, M.A.; Cinieri, S.; Bianco, R.; Ciardiello, F. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Treatment of small cell lung cancer

Critical Reviews in Oncology/Hematology
2014 | Journal article
DOI: 10.1016/j.critrevonc.2014.03.003
EID:

2-s2.0-84904599936
Contributors: Morabito, A.; Carillio, G.; Daniele, G.; Piccirillo, M.C.; Montanino, A.; Costanzo, R.; Sandomenico, C.; Giordano, P.; Normanno, N.; Perrone, F. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations

Journal of Thoracic Oncology
2013 | Journal article
DOI: 10.1097/JTO.0b013e318286cc26
EID:

2-s2.0-84880887864
Contributors: Morabito, A.; Costanzo, R.; Rachiglio, A.M.; Pasquale, R.; Sandomenico, C.; Franco, R.; Montanino, A.; De Lutio, E.; Rocco, G.; Normanno, N.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: Current evidence and future perspectives

Expert Review of Anticancer Therapy
2013 | Journal article
DOI: 10.1586/14737140.2013.845092
EID:

2-s2.0-84886390038
Contributors: Costanzo, R.; Montanino, A.; Di Maio, M.; Piccirillo, M.C.; Sandomenico, C.; Giordano, P.; Daniele, G.; Franco, R.; Perrone, F.; Rocco, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer

Anti-Cancer Agents in Medicinal Chemistry
2013 | Journal article
DOI: 10.2174/18715206113139990076
EID:

2-s2.0-84880163343
Contributors: Di Maio, M.; Costanzo, R.; Giordano, P.; Piccirillo, M.C.; Sandomenico, C.; Montanino, A.; Carillio, G.; Muto, P.; Jones, D.R.; Daniele, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study

Lung Cancer
2013 | Journal article
DOI: 10.1016/j.lungcan.2013.04.008
EID:

2-s2.0-84878975454
Contributors: Morabito, A.; Gebbia, V.; Di Maio, M.; Cinieri, S.; Viganò, M.G.; Bianco, R.; Barbera, S.; Cavanna, L.; De Marinis, F.; Montesarchio, V. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Bevacizumab in non small cell lung cancer: Development, current status and issues

Current Medicinal Chemistry
2012 | Journal article
DOI: 10.2174/092986712799320673
EID:

2-s2.0-84858168405
Contributors: Sandomenico, C.; Costanzo, R.; Carillio, G.; Piccirillo, M.C.; Montanino, A.; Di Maio, M.; Rocco, G.; Normanno, N.; Perrone, F.; Morabito, A.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Cetuximab in non-small-cell lung cancer

Expert Review of Anticancer Therapy
2012 | Journal article
DOI: 10.1586/era.11.178
EID:

2-s2.0-84856844739
Contributors: Carillio, G.; Montanino, A.; Costanzo, R.; Sandomenico, C.; Piccirillo, M.C.; Di Maio, M.; Daniele, G.; Giordano, P.; Bryce, J.; Normanno, N. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Is preoperative endoscopic biliary drainage indicated for jaundiced patients with resectable pancreatic cancer?

Current Drug Targets
2012 | Journal article
DOI: 10.2174/138945012800564167
EID:

2-s2.0-84860789125
Contributors: de Bellis, M.; Palaia, R.; Sandomenico, C.; Di Girolamo, E.; Cascella, M.; Fiore, F.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Positron emission tomography and circulating tumor cells to monitor a dramatic response to Gefitinib

Journal of Thoracic Oncology
2012 | Journal article
DOI: 10.1097/JTO.0b013e3182653da2
EID:

2-s2.0-84867879786
Contributors: Morabito, A.; Sandomenico, C.; Costanzo, R.; Montanino, A.; Caraco, C.; De Lutio, E.; Bevilacqua, S.; Pasquale, R.; Caronna, A.; Botti, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

Lung Cancer
2012 | Journal article
DOI: 10.1016/j.lungcan.2012.01.002
EID:

2-s2.0-84860543344
Contributors: Di Maio, M.; Signoriello, S.; Morabito, A.; Rossi, A.; Maione, P.; Piantedosi, F.; Bilancia, D.; Cigolari, S.; Barbera, S.; Gebbia, V. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Central venous device-related thrombosis as imaged with MDCT in oncologic patients: Prevalence and findings

Acta Radiologica
2011 | Journal article
DOI: 10.1258/ar.2010.100294
EID:

2-s2.0-79958782590
Contributors: Catalano, O.; Di Castelguidone, E.D.L.; Sandomenico, C.; Petrillo, M.; Aprea, P.; Granata, V.; D'Errico, A.G.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF regimen) in patients with metastatic colorectal cancer: The southern Italy cooperative oncology group experience

Clinical Colorectal Cancer
2011 | Journal article
DOI: 10.3816/CCC.2011.n.006
EID:

2-s2.0-80053410666
Contributors: Comella, P.; Massidda, B.; Natale, D.; Putzu, C.; Sandomenico, C.; Filippelli, G.; Palmeri, S.; Condemi, G.; Vessia, G.; Barberis, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Gefitinib in non small cell lung cancer

Journal of Biomedicine and Biotechnology
2011 | Journal article
DOI: 10.1155/2011/815269
EID:

2-s2.0-80052674928
Contributors: Morabito, A.; Costanzo, R.; Piccirillo, M.C.; Sandomenico, C.; Carillio, G.; Montanino, A.; Daniele, G.; Giordano, P.; Bryce, J.; De Feo, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: Long-term outcome

International Journal of Radiation Oncology Biology Physics
2011 | Journal article
DOI: 10.1016/j.ijrobp.2009.12.007
EID:

2-s2.0-79551487814
Contributors: Avallone, A.; Delrio, P.; Pecori, B.; Tatangelo, F.; Petrillo, A.; Scott, N.; Marone, P.; Aloi, L.; Sandomenico, C.; Lastoria, S. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet

Acta Oncologica
2010 | Journal article
DOI: 10.3109/02841860903369540
EID:

2-s2.0-76649138311
Contributors: Comella, P.; Casaretti, R.; Manzo, R.; Sandomenico, C.; Licenziato, M.; Avallone, A.; Franco, L.; Massidda, B.; Filippelli, G.; Putzu, C. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Vandetanib: An overview of its clinical development in NSCLC and other tumors

Drugs of Today
2010 | Journal article
DOI: 10.1358/dot.2010.46.9.1516989
EID:

2-s2.0-79955891953
Contributors: Morabito, A.; Piccirillo, M.C.; Costanzo, R.; Sandomenico, C.; Carillio, G.; Daniele, G.; Giordano, P.; Bryce, J.; Carotenuto, P.; La Rocca, A. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: A multicenter phase II trial of the Southern Italy Cooperative Oncology Group

Cancer Chemotherapy and Pharmacology
2009 | Journal article
DOI: 10.1007/s00280-009-0938-4
EID:

2-s2.0-69049094922
Contributors: Comella, P.; Lorusso, V.; Maiorino, L.; Casaretti, R.; Cannone, M.; Massidda, B.; Putzu, C.; Leo, S.; Roselli, M.; Mancarella, S. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Role of oxaliplatin in the treatment of colorectal cancer

Therapeutics and Clinical Risk Management
2009 | Journal article
EID:

2-s2.0-77949450168
Contributors: Comella, P.; Casaretti, R.; Sandomenico, C.; Avallone, A.; Franco, L.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Capecitabine, alone and in combination, in the management of patients with colorectal cancer: A review of the evidence

Drugs
2008 | Journal article
DOI: 10.2165/00003495-200868070-00005
EID:

2-s2.0-43249090877
Contributors: Comella, P.; Casaretti, R.; Sandomenico, C.; Avallone, A.; Franco, L.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Efficacy and tolerability of capecitabine, alone and in combination, in the management of colon cancer patients: A review of the evidence,Efficacia e tollerabilità della capecitabina, da sola ed in associazione, nel trattamento dei pazienti con tumore del colon: Revisione delle evidenze cliniche

Trends in Medicine
2007 | Journal article
EID:

2-s2.0-34948851460
Contributors: Sandomenico, C.; Casaretti, R.; Franco, L.; Cornella, P.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Age-tailored CHOP schedule (CEOPm) allows to maintain the dose intensity in aggressive non Hodgkin lymphomas of the elderly,Chemioterapia dose-dense nell'anziano affetto da linfoma non Hodgkin: La schedula CEOPm consente il mantenimento di una adeguata dose-intensity

Geriatric and Medical Intelligence
2006 | Journal article
EID:

2-s2.0-33749607068
Contributors: Rea, A.; Gadaleta-Caldarola, G.; Colangelo, M.; Infusino, S.; Filice, A.; Mastroianni, C.; Sandomenico, C.; Manfredi, C.; Palazzo, S.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: A phase II study in pretreated patients with metastatic colorectal cancer

Anti-Cancer Drugs
2006 | Journal article
DOI: 10.1097/01.cad.0000224452.62071.ce
EID:

2-s2.0-33748463224
Contributors: Comella, P.; Massidda, B.; Palmeri, S.; Putzu, C.; De Rosa, V.; Izzo, F.; Fiore, F.; Casaretti, R.; Sandomenico, C.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

de Gramont schedule is a very low toxic and effective regimen in low performance status patients affected by metastatic gastric cancer: preliminary report.

Tumori
2002 | Journal article
EID:

2-s2.0-0036654295
Contributors: Rea, A.; Caldarola, G.G.; Sandomenico, C.; Colangelo, M.; Filice, A.; Mastroianni, C.M.; Biamonte, R.; Palazzo, S.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas

Cancer
2000 | Journal article
DOI: 10.1002/1097-0142(20000901)89:5<1065::AID-CNCR16>3.0.CO;2-T
EID:

2-s2.0-0034284073
Contributors: Pepe, S.; Ruggiero, A.; D'Acquisto, M.; De Laurentiis, M.; De Placido, S.; Sandomenico, C.; Staibano, S.; De Rosa, G.; Lucariello, A.; D'Armiento, M. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27

Cell Growth and Differentiation
2000 | Journal article
EID:

2-s2.0-0033764652
Contributors: Baldassarre, G.; Boccia, A.; Bruni, P.; Sandomenico, C.; Barone, M.V.; Pepe, S.; Angrisano, T.; Belletti, B.; Motti, M.L.; Fusco, A. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Key role of the cyclin-dependent kinase inhibitor p27(kip1) for embryonal carcinoma cell survival and differentiation

Oncogene
1999 | Journal article
DOI: 10.1038/sj.onc.1203031
EID:

2-s2.0-0033523929
Contributors: Baldassarre, G.; Barone, M.V.; Belletti, B.; Sandomenico, C.; Bruni, P.; Spiezia, S.; Boccia, A.; Vento, M.T.; Romano, A.; Pepe, S. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1

Oncogene
1997 | Journal article
DOI: 10.1038/sj.onc.1201260
EID:

2-s2.0-9844267973
Contributors: Baldassarre, G.; Romano, A.; Armenante, F.; Rambaldi, M.; Paoletti, I.; Sandomenico, C.; Pepe, S.; Staibano, S.; Salvatore, G.; De Rosa, G. et al.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

Synergistic inhibition of growth and induction of apoptosis by 8- chloro-cAMP and paclitaxel or cisplatin in human cancer cells

Cancer Research
1997 | Journal article
EID:

2-s2.0-0030722087
Contributors: Tortora, G.; Di Isernia, G.; Sandomenico, C.; Bianco, R.; Pomatico, G.; Pepe, S.; Bianco, A.R.; Ciardiello, F.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier

8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells

International Journal of Oncology
1996 | Journal article
EID:

2-s2.0-0029824819
Contributors: Di Isernia, G.; Ciardiello, F.; Sandomenico, C.; Pepe, S.; Bianco, A.R.; Tortora, G.
Source: Self-asserted source
Claudia Sandomenico via Scopus - Elsevier
How many people are using ORCID?